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Pulmonary actinomycosis complicated by fistula of the chest wall
Abstract
Actinomycosis is a rare disease caused by Actinomyces spp. The clinical and radiological picture of the disease is uncharacter-
istic, which delays the diagnosis and can lead to complications. We present a case of pulmonary actinomycosis complicated by 
a chest wall fistula in a 43-year-old man with advanced tooth decay. The patient was admitted to our Department due to a chest 
wall fistula with bloody discharge. A few months earlier, he was treated with antibiotics for pneumonia. Since then, weakness, 
exertional dyspnoea, and weight loss had been observed. On admission, increased inflammatory markers were found in laboratory 
tests. Chest computed tomography (CT) revealed right-sided encapsulated pleural fluid collection containing gas bubbles, pleural 
thickening, anterior thoracic wall soft tissues thickening and subcutaneous fat stranding. CT suggested an empyema or a breast 
either pleural malignancy. The picture suggested a breast or pleural tumour to differentiate with an empyema. Videothoracos-
copy was performed, the histological examination of the collected samples revealed granulation tissue and bacterial colony of a 
morphology corresponding to Actinomyces spp. Pulmonary actinomycosis was diagnosed. Antibiotic therapy according to the 
guidelines was initiated and dental treatment was recommended. Healing of the fistula and significant regression of lesions in 
the right lung were achieved. Although it is a rare disease, actinomycosis should be considered in the differential diagnosis of 
any chronic infiltrative lung lesions.
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Introduction
Actinomycosis is a rare disease caused by 
Actinomyces spp., gram-positive anaerobic bac-
teria that normally live in the human oral cav-
ity, digestive tract and urogenital system as 
commensals. A. israelli is considered to be the 
most common cause of the disease, followed by 
A. naeslundi and A. mayeari [1]. These bacteria
usually coexist with other microorganisms that
reduce the oxygen concentration in the environ-
ment and weaken the body defences, allowing
Actinomyces to grow [2]. The disease can affect
many organ systems. Infections of the craniofacial
area are the most common, followed by gastro-
intestinal and respiratory disease [3]. It may also
involve the central nervous system, bones and
joints and the genitourinary system [4]. Lung in-
fection occurs as a result of aspiration of infected 
contents from the oral cavity and the gastrointes-
tinal tract [5]. Risk factors include lack of proper 
oral hygiene, alcoholism, chronic respiratory 
diseases such as chronic obstructive pulmonary 
disease, bronchiectasis, history of pulmonary 
tuberculosis, immunosuppression in the course 
of other diseases or treatment [4]. Males are more 
likely to be affected than females, which may be 
associated with less hygiene and more frequent 
facial injuries. Infection can occur at any age, but 
most often occurs in people aged 20–50 [5]. We 
present the case of a 43-year-old man suffering 
from actinomycosis complicated by a fistula of 
the chest wall. The aim of the study is to draw 
doctors’ attention to the need for considering this 
disease at an early stage of differential diagnosis 
of ambiguous clinical cases.
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Case report
A 43-year-old smoking man with no history 
of chronic diseases was admitted to the National 
Tuberculosis and Lung Diseases Research Insti-
tute due to a chest wall fistula. His problem start-
ed five months earlier with dyspnoea and chest 
pain, for which he was evaluated in a different 
hospital. Tests performed at that time revealed 
significantly increased blood inflammation mark-
ers and right-sided pleural effusion up to the 8th 
rib with accompanying lung consolidations on 
chest x-ray. Community-acquired pneumonia 
was diagnosed. The patient refused hospital ad-
mission, so ambulatory antibiotic therapy was 
initiated (amoxicillin with clavulanic acid and 
clarithromycin). Despite treatment, mild chest 
pain persisted, deterioration of exercise tolerance 
and gradual weight loss developed. A fistula ap-
peared with time in the right nipple area, oozing 
bloody discharge. Fever was not observed.
On admission to the Department, the patient’s 
blood pressure was 140/95 mm Hg, heart rate reg-
ular 104/min, oxygen saturation 98% on room air. 
Chest auscultation revealed a decrease in breath-
ing sounds at the base of the right lung, no adven-
titious sounds were heard. There were two striking 
findings from inspection: advanced tooth decay 
and cellulitis with fistula in the right mammary 
area. Blood tests revealed increased inflammatory 
markers and abnormal coagulation parameters 
(Table 1). Chest X-ray showed a large amount of 
fluid in the right pleural cavity (Figure 1). Contrast 
enhanced CT with pulmonary angiogram exclud-
ed pulmonary embolism. It revealed right-sided 
encapsulated pleural fluid collection containing 
gas bubbles, pleural thickening and contrast en-
hancement and features of anterior thoracic wall 
involvement: soft tissues thickening, discreet 
rib destruction and subcutaneous fat stranding 
(Figure 2). CT suggested a pleural empyema or 
a breast either pleural malignancy. Thoracentesis 
was performed and trace amount of bloody fluid 
was obtained — pH 8, brown colour, erythrocytes 
3.85 x 1012/L; haemoglobin 11,8 g/dL; the smear 
was dominated by leukocytes — 77%. The fistula 
swab cultures yielded the growth of Acinetobacter 
baumani complex. For diagnostic and therapeutic 
reasons, the patient was referred for video-assisted 
thoracoscopic surgery (VATS). A pleural empy-
ema was evacuated, and the anterior chest wall 
was incised. Material for microbiological tests 
and histopathological evaluation was collected. 
Parvimonas micra was cultured on the pleural 
effusion in anaerobic conditions, and the culture 
was sterile under aerobic conditions. The smear 
of pleural fluid was negative for acid-fast bacteria 
(final cultures were also negative), and there was 
no fungal growth. The patient was managed with 
pleural drainage and antibiotic therapy in accor-
dance with antibiogram. Clinical improvement 
was achieved. As results of the histopathological 
examination of the chest wall phlegmon became 
available, they revealed a nonspecific granulation 
tissue with massive inflammatory infiltrate rich in 
neutrophils and plasma cells and with multiple 
colonies of densely packed bacteria. The colonies 
were covered by eosinophilic proteinous deposits 
(Splendore-Hoeppli reaction). Grocott methenam-
ine-silver stain (GMS) revealed the filamentous 
structure of the bacteria. Morphology of micro-
organisms corresponded with Actinomyces spp. 
(Figure 3). The culture targeted at Actinomyces 
spp were negative. Based on histopathological 
analysis and corresponding clinical picture, the 
diagnosis of actinomycosis complicated by fistula 
of the chest wall was established. The antibiot-
ic therapy was started in accordance with the 
guidelines for treating actinomycosis (intravenous 
therapy with amoxicillin with clavulanic acid for 
2 weeks during hospitalisation followed by oral 
treatment with amoxicillin 3g/day at home) and 
dental treatment was recommended. During the 
initial treatment, the fistula was healed and the 
lesions in the right lung regressed significantly. In 
good general condition, the patient was discharged 
home. A follow-up hospitalisation was planned, 
but for economic reasons, it was not performed, 
and antibiotic therapy was discontinued approxi-
mately 3 weeks after discharge. The further course 
of the disease remains unknown.
Discussion
The clinical presentation of the respirato-
ry system actinomycosis is not characteristic, 
Table 1. Laboratory tests results
Parameter Result Norm
Leukocytes [× 103/mm3] 12 4.23–9.07
C-reactive protein (CRP) [mg/L] 122 < 10
D- dimers [ng/mL] 1242 < 500
Activated partial thromboplastin 




INR — international normalized ratio
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Figure 1. Posteroanterior chest radiograph shows a large amount of fluid in right pleural cavity
Figure 2. Axial contrast-enhanced CT image reveals right-sided encapsulated pleural fluid collection (arrow 1) containing gas bubbles (arrow 2), 
pleural thickening and contrast enhancement (arrow 3), anterior thoracic wall soft tissues thickening (arrow 4), subcutaneous fat stranding (arrow 5)
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which is responsible for diagnostic difficulties 
and mistakes. It has been estimated that it takes 
approximately 3 months to make a proper diag-
nosis of pulmonary actinomycosis [6]. Initially, 
the disease may be asymptomatic. Later on, 
chronic cough, dyspnoea, chest pain, fever or low-
grade fever, deterioration of exercise tolerance, 
weight loss, sweating, and recurrent respiratory 
infections appear. There are reports of massive 
or recurrent haemoptysis requiring pulmonary 
embolisation as the main clinical manifestation 
[7, 8]. In our case, the first symptoms of the dis-
ease were dyspnoea and chest pain. On the basis 
of performed tests, pneumonia was diagnosed 
and antibiotic therapy was initiated. Despite the 
treatment, the patient observed a deterioration 
of exercise tolerance, weight loss and local chest 
skin changes, which prompted him to seek further 
medical assistance. First, chest CT was performed 
5 months after the first symptoms. It indicated 
right-sided empyema and/or breast or pleural 
neoplasm. According to the literature, pulmonary 
Figure 3. Microphotography of a colony of Actinomyces. A, B. Low-power of densely packed tangles of bacterial colony (A) surrounded by granu-
locytes (gran) and histiocytes (hist). C. High-power of bacterial colony (A) with eosinophilic deposits of proteinous exudate at the edge - so-called 
Splendore-Hoeppli phenomenon (S-P). D. GMS stain highlighted the filamentous structure of bacteria at the periphery of the colony (A and C — 





Advances in Respiratory Medicine 2021, vol. 89
536 www.journals.viamedica.pl
nodular infiltrates are the most frequent radio-
logical findings at the initial stage of the disease. 
Other observations include cavitation within the 
nodular infiltrates, central necrosis, ground-glass 
opacities, subpleural consolidation, mediastinal 
lymph nodes enlargement, pleural thickening and 
effusion [1, 7]. At that stage, it is very difficult 
to differentiate actinomycosis from pulmonary 
tuberculosis, neoplasms, lung abscesses or fun-
gal lesions. In further course of the disease, the 
lesions may progress locally and involve adjacent 
structures. The formation of fistulas (e.g., into 
the oesophagus or through the chest wall) and 
abscesses within the respiratory system is a rare 
form of the disease and it appears most common-
ly at the late stage when not properly treated 
[4]. For this reason, the presented case deserves 
special attention. Five months elapsed between 
first symptoms and the diagnostic work-up in our 
Department. This time was sufficient for the de-
velopment of complications. This shows how im-
portant it is to consider actinomycosis at an early 
stage of the differential diagnosis, especially if no 
improvement is achieved with treatment targeted 
at the most common respiratory infection agents.
Diagnosis of the disease is based on the pres-
ence of Actinomyces spp in the microbiological 
examination and/or findings in the histopatholog-
ical test. Bronchoscopy may be helpful, however, 
there is no bronchoscopic pattern characteristic 
of actinomycosis. Samples collected during the 
examination can be considered diagnostic only in 
the presence of pulmonary cavities [3, 4]. Other-
wise, it is difficult to decide whether the bacteria 
are the causative factor or just a contamination. 
Suzuki et al. [7] reported a case where pulmonary 
actinomycosis was diagnosed by transbronchial 
lung biopsy, but it is to remember that the diagno-
sis was made based on the tissue histopatholog-
ical examination, not the cultures. Ding et al. [5] 
and Tabarsi et al. [8] presented similar cases. In 
our patient, bronchoscopy was not performed 
because the disease process seemed to originate 
from the chest wall. Instead, urgent VATS was un-
dertaken. The surgical intervention was the most 
appropriate, both for diagnostic and therapeutic 
reasons. Surgical or CT-guided lung biopsy is also 
recognised as an appropriate diagnostic tool for 
pulmonary actinomycosis [4]. Pleural fluid testing 
is reasonable, but it rarely yields positive results 
[3, 9]. Samples for Actinomyces spp cultures 
should be collected under anaerobic conditions 
and growth should last 15–20 days. However, 
positive results are obtained in less than 50% of 
cases. Reasons include recent antibiotic therapy, 
abundant growth of other microorganisms, com-
plicated procedure of specimen collection and the 
necessity to use non-standard conditions [3, 8]. 
In our case, cultures for Actinomyces, collected 
during thoracentesis and VATS, were negative. It 
is difficult to say which of the above-mentioned 
reasons played a role here. Perhaps it was influ-
enced by other microorganisms’ growth (Acine-
tobacter baumani complex, Parvimonas micra). 
In the presented case, histopathological findings 
were crucial for the final diagnosis. Characteristic 
lesions in the histological examinations include 
inflammatory granulation tissue with necrotisis 
and colonies of gram-positive filamentous bac-
teria. Macroscopically, bacterial colonies form 
yellowish clumps, so-called sulfur granules of 
a diameter of 0.1–1 mm. It is important not to 
consider them pathognomonic as they can also 
occur in other diseases such as nocardiosis or 
mycoses [4]. The possibility of using molecular 
techniques in the diagnosis of actinomycosis has 
been reported [6].
The treatment scheme of pulmonary acti-
nomycosis remains controversial. Antibiotics 
penetration to the infection site is poor due to low 
vascularisation of the lesions and a large number 
of fibrous lesions [6]. Therefore, high doses of an-
tibiotics and prolonged time of treatment should 
be applied. Standard treatment regimen includes 
the use of intravenous penicillin (18–24 mln 
units/day) for 2 to 6 weeks followed by oral treat-
ment for 6 to 12 months (amoxicillin 3 g/day) 
[1, 4, 10]. Alternative treatments are based on 
the use of clindamycin or macrolides. [2, 4, 11]. 
Actinomyces spp do not produce β-lactamase, so 
there is no need to use their inhibitors, however, 
some authors describe effective therapy with 
them [12]. The treatment should be continued for 
at least 3 months to prevent local complications 
like fistulas or phlegmon of the chest wall and 
disease recurrence [4]. However, some authors 
advocate shortening the therapy to less than 
6 months, including reducing the intravenous 
treatment phase to less than 14 days [10]. The 
argument for such approach is earlier detection 
of the disease nowadays than it was in the past, 
when the disease was often diagnosed at the late 
stage, with complications [10]. Zhang et al. [3] 
analysed 145 cases of actinomycosis and reported 
an average treatment duration of 4.5 months. All 
patients were considered cured. Kinner et al. [13] 
described 19 patients who were considered cured 
after an average treatment duration of 6 weeks. It 
is suggested to consider discontinuation of anti-
biotic therapy 1–2 months after disappearance of 
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clinical and radiological symptoms of the disease. 
Surgical treatment may also allow for shorten-
ing the antibiotic therapy [10]. Indications for 
surgery are massive/recurrent haemoptysis, no 
improvement after antibiotic therapy or the need 
to supplement it in case of abscesses, fistulas or 
phlegmon. In addition, invasive procedures are 
performed to rule out neoplasms. In case of mas-
sive pleural effusion, drainage should be used 
[6]. Quickly applied, it can also shorten the time 
of antibiotic therapy. However, the small number 
of described cases does not allow to confirm this 
unequivocally.
Conclusions
Pulmonary actinomycosis is a rare disease, 
but it should be considered in all patients with 
progressing infiltrative lung/pleural pathology. 
Once the diagnosis is made, proper antibiotic 
therapy should be started immediately. Delay 
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